Search

Your search keyword '"Novoplansky, Ofra"' showing total 20 results

Search Constraints

Start Over You searched for: Author "Novoplansky, Ofra" Remove constraint Author: "Novoplansky, Ofra"
20 results on '"Novoplansky, Ofra"'

Search Results

5. Dual inhibition of HERs and PD-1 counteract resistance in KRASG12C-mutant head and neck cancer.

6. Abstract P42: Beyond the Canonical: uORF-encoded Micro Peptides as Novel Kinase Inhibitors in Cancer Therapy

8. Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer

9. Data from TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors

10. Supplementary Figures from TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors

11. Supplementary Tables from TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors

14. MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer

16. MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer

17. TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors

18. TGF-Beta-Activated Cancer-Associated Fibroblasts Limit Cetuximab Efficacy in Preclinical Models of Head and Neck Cancer

19. MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer

Catalog

Books, media, physical & digital resources